BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 29975353)

  • 1. Pathologic Evaluation of Surgical Margins in Pancreatic Cancer Specimens Using Color Coding With Tissue Marking Dyes.
    Takahashi D; Kojima M; Sugimoto M; Kobayashi S; Takahashi S; Konishi M; Gotohda N; Nagino M
    Pancreas; 2018 Aug; 47(7):830-836. PubMed ID: 29975353
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Usefulness of Color Coding Resected Samples from a Pancreaticoduodenectomy with Tissue Marking Dyes for a Detailed Examination of Surgical Margin Surrounding the Uncinate Process of the Pancreas.
    Mizutani S; Suzuki H; Aimoto T; Yamagishi S; Mishima K; Watanabe M; Kitayama Y; Motoda N; Isshiki S; Uchida E
    J Nippon Med Sch; 2017; 84(1):32-40. PubMed ID: 28331142
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Superior Mesenteric Artery Margin of Posttherapy Pancreaticoduodenectomy and Prognosis in Patients With Pancreatic Ductal Adenocarcinoma.
    Liu L; Katz MH; Lee SM; Fischer LK; Prakash L; Parker N; Wang H; Varadhachary GR; Wolff RA; Lee JE; Pisters PW; Maitra A; Fleming JB; Estrella J; Rashid A; Wang H
    Am J Surg Pathol; 2015 Oct; 39(10):1395-403. PubMed ID: 26200098
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical impacts of resection margin status and clinicopathologic parameters on pancreatic ductal adenocarcinoma.
    Jamiyan T; Shiraki T; Kurata Y; Ichinose M; Kubota K; Imai Y
    World J Surg Oncol; 2020 Jun; 18(1):137. PubMed ID: 32571348
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prediction of Recurrence With KRAS Mutational Burden Using Ultrasensitive Digital Polymerase Chain Reaction of Radial Resection Margin of Resected Pancreatic Ductal Adenocarcinoma.
    Kim SJ; Kim MJ; Han JS; Sung YN; An S; Lee JH; Song KB; Hwang DW; Lee SS; Cho H; Kim SC; Eshleman JR; Hong SM
    Pancreas; 2019 Mar; 48(3):400-411. PubMed ID: 30747828
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prospective assessment of resection margin status following pancreaticoduodenectomy for pancreatic ductal adenocarcinoma after standardisation of margin definitions.
    Pine JK; Haugk B; Robinson SM; Darne A; Wilson C; Sen G; French JJ; White SA; Manas DM; Charnley RM
    Pancreatology; 2020 Apr; 20(3):537-544. PubMed ID: 31996296
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact of margin status determined by the one-millimeter rule on tumor recurrence and survival following pancreaticoduodenectomy for pancreatic ductal adenocarcinoma.
    Nitta T; Nakamura T; Mitsuhashi T; Asano T; Okamura K; Tsuchikawa T; Tamoto E; Murakami S; Noji T; Kurashima Y; Ebihara Y; Nakanishi Y; Shichinohe T; Hirano S
    Surg Today; 2017 Apr; 47(4):490-497. PubMed ID: 27677294
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Superior mesenteric artery margin in pancreaticoduodenectomy for pancreatic adenocarcinoma.
    Liu DN; Lv A; Tian ZH; Tian XY; Guan XY; Dong B; Zhao M; Hao CY
    Oncotarget; 2017 Jan; 8(5):7766-7776. PubMed ID: 27999192
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Resection margin status at the portomesenteric axis may not determine oncologic outcome after pancreaticoduodenectomy for lymph node-positive pancreatic ductal adenocarcinoma.
    Katou S; Wenning AS; Aeschbacher P; Morgul H; Becker F; Pascher A; Gloor B; Strücker B; Andreou A
    Surgery; 2023 Jul; 174(1):91-99. PubMed ID: 37121858
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathological Margin Clearance and Survival After Pancreaticoduodenectomy in a US and European Pancreatic Center.
    van Roessel S; Kasumova GG; Tabatabaie O; Ng SC; van Rijssen LB; Verheij J; Najarian RM; van Gulik TM; Besselink MG; Busch OR; Tseng JF
    Ann Surg Oncol; 2018 Jun; 25(6):1760-1767. PubMed ID: 29651577
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Surgical margins for duodenopancreatectomy.
    Coppola R; Cartillone M; Borzomati D; Nappo G; Valeri S; Petitti T; Perrone G
    Updates Surg; 2016 Sep; 68(3):279-285. PubMed ID: 27778242
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microscopic margins and patterns of treatment failure in resected pancreatic adenocarcinoma.
    Gnerlich JL; Luka SR; Deshpande AD; Dubray BJ; Weir JS; Carpenter DH; Brunt EM; Strasberg SM; Hawkins WG; Linehan DC
    Arch Surg; 2012 Aug; 147(8):753-60. PubMed ID: 22911074
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Redefining the R1 resection in patients with pancreatic ductal adenocarcinoma.
    Markov P; Satoi S; Kon M
    J Hepatobiliary Pancreat Sci; 2016 Sep; 23(9):523-32. PubMed ID: 27524388
    [TBL] [Abstract][Full Text] [Related]  

  • 14. R1 resection in pancreatic cancer has significant impact on long-term outcome in standardized pathology modified for routine use.
    Rau BM; Moritz K; Schuschan S; Alsfasser G; Prall F; Klar E
    Surgery; 2012 Sep; 152(3 Suppl 1):S103-11. PubMed ID: 22766366
    [TBL] [Abstract][Full Text] [Related]  

  • 15. R Status is a Relevant Prognostic Factor for Recurrence and Survival After Pancreatic Head Resection for Ductal Adenocarcinoma.
    Crippa S; Giannone F; Schiavo Lena M; Belfiori G; Partelli S; Tamburrino D; Delpini R; Pagnanelli M; Pecorelli N; Balzano G; Doglioni C; Falconi M
    Ann Surg Oncol; 2021 Aug; 28(8):4602-4612. PubMed ID: 33393031
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Posterior Superior Mesenteric Artery (SMA) First Approach vs. Standard Pancreaticoduodenectomy in Patients with Resectable Periampullary Cancers: a Prospective Comparison Focusing on Circumferential Resection Margins.
    Pal S; George J; Singh AN; Mathur S; Dash NR; Garg P; Sahni P; Chattopadhyay TK
    J Gastrointest Cancer; 2018 Sep; 49(3):252-259. PubMed ID: 28315190
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Positive Resection Margins Detected by Standardized Study of a Pancreaticoduodenectomy Sample: Is There Any Real Impact on Long-term Survival?
    Di Martino M; Muñoz de Nova JL; Guijarro Rojas M; Alday Muñoz E; Martín-Pérez E
    Cir Esp (Engl Ed); 2020 Mar; 98(3):127-135. PubMed ID: 31784034
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lymph node metastases in resected pancreatic ductal adenocarcinoma: predictors of disease recurrence and survival.
    Morales-Oyarvide V; Rubinson DA; Dunne RF; Kozak MM; Bui JL; Yuan C; Qian ZR; Babic A; Da Silva A; Nowak JA; Khalaf N; Brais LK; Welch MW; Zellers CL; Ng K; Chang DT; Miksad RA; Bullock AJ; Tseng JF; Swanson RS; Clancy TE; Linehan DC; Findeis-Hosey JJ; Doyle LA; Hornick JL; Ogino S; Fuchs CS; Hezel AF; Koong AC; Wolpin BM
    Br J Cancer; 2017 Dec; 117(12):1874-1882. PubMed ID: 28982112
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Microscopically positive (R1) resections do not affect survival in pancreatic head cancer.
    Mois E; Graur F; Al-Hajjar N; Zaharie F; Bartos A; Bodea R; Zaharie T; Rusu I; Iancu C
    Ann Ital Chir; 2017; 88():491-496. PubMed ID: 29339587
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The prognostic influence of intrapancreatic tumor location on survival after resection of pancreatic ductal adenocarcinoma.
    Ruess DA; Makowiec F; Chikhladze S; Sick O; Riediger H; Hopt UT; Wittel UA
    BMC Surg; 2015 Nov; 15():123. PubMed ID: 26615588
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.